CO2018004630A2 - Composición de una vacuna de neospora - Google Patents
Composición de una vacuna de neosporaInfo
- Publication number
- CO2018004630A2 CO2018004630A2 CONC2018/0004630A CO2018004630A CO2018004630A2 CO 2018004630 A2 CO2018004630 A2 CO 2018004630A2 CO 2018004630 A CO2018004630 A CO 2018004630A CO 2018004630 A2 CO2018004630 A2 CO 2018004630A2
- Authority
- CO
- Colombia
- Prior art keywords
- protein
- present
- composition
- compositions
- protein compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/012—Coccidia antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/10—Protozoa; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
RESUMEN La presente invención incluye nuevas composiciones proteínicas, métodos de producción de dichas composiciones proteínicas, composiciones farmacéuticas que comprenden las mencionadas composiciones proteínicas y los métodos para tratar infecciones causadas por Neospora caninum. En particular, la presente invención se refiere a la composición proteínica que comprende las proteínas especificadas en la Tabla A en un cantidad de al menos sobre unas 2 veces (fold change) más que la misma proteína presente en el taquizoíto entero, como se determina por el análisis cuantitativo sin marcaje de cromatografía líquida acoplada a espectrometría de masas (LC-MS/MS).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15382532 | 2015-10-28 | ||
| PCT/EP2016/076137 WO2017072325A1 (en) | 2015-10-28 | 2016-10-28 | Neospora vaccine composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2018004630A2 true CO2018004630A2 (es) | 2018-07-19 |
Family
ID=54427686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2018/0004630A CO2018004630A2 (es) | 2015-10-28 | 2018-04-30 | Composición de una vacuna de neospora |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10864260B2 (es) |
| EP (1) | EP3368070B9 (es) |
| AU (1) | AU2016347636B2 (es) |
| BR (1) | BR112018008527A2 (es) |
| CA (1) | CA3003343C (es) |
| CL (1) | CL2018001130A1 (es) |
| CO (1) | CO2018004630A2 (es) |
| ES (1) | ES2960032T3 (es) |
| IL (1) | IL258976B (es) |
| MX (1) | MX2018005254A (es) |
| NZ (1) | NZ742210A (es) |
| WO (1) | WO2017072325A1 (es) |
| ZA (1) | ZA201803039B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110183527B (zh) * | 2019-05-21 | 2021-03-12 | 中国农业大学 | 一种新孢子虫NcMIC26抗原及其应用 |
| CN116284316B (zh) * | 2023-01-17 | 2023-12-29 | 西湖大学 | 一种针对原肌球蛋白受体激酶a的d5结构域的d-蛋白抑制剂及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5240704A (en) | 1983-07-03 | 1993-08-31 | Kitasato Kenkyusho | Vaccine, antibodies & antibody-containing compositions for inhibiting human dental caries induced by streptococcus mutans |
| US5707617A (en) | 1994-03-21 | 1998-01-13 | The Regents Of The University Of California | Bovine neospora isolates |
| EP0841392B1 (en) | 1996-11-12 | 2004-07-14 | Pfizer Inc. | Attenuated live neospora vaccine |
| BR9803232A (pt) * | 1997-08-26 | 2000-01-11 | Pfizer Prod Inc | Vaicna de neospora. |
| DE69836976T2 (de) | 1997-10-20 | 2007-11-08 | Bayer Corp. | Neospora impstoff |
| WO2004026903A2 (en) | 2002-09-20 | 2004-04-01 | Akzo Nobel N.V. | Live antenuated parasite vaccine |
| CR6773A (es) | 2002-10-08 | 2006-05-30 | Wyeth Corp | Vacuna contra la myeloencephalitis protozoal equina |
| US7887818B2 (en) | 2008-02-20 | 2011-02-15 | The United States Of America As Represented By The Secretary Of Agriculture | Neospora caninum vaccine |
-
2016
- 2016-10-28 MX MX2018005254A patent/MX2018005254A/es unknown
- 2016-10-28 IL IL258976A patent/IL258976B/en unknown
- 2016-10-28 WO PCT/EP2016/076137 patent/WO2017072325A1/en active Application Filing
- 2016-10-28 AU AU2016347636A patent/AU2016347636B2/en active Active
- 2016-10-28 CA CA3003343A patent/CA3003343C/en active Active
- 2016-10-28 ES ES16795246T patent/ES2960032T3/es active Active
- 2016-10-28 BR BR112018008527A patent/BR112018008527A2/pt active Search and Examination
- 2016-10-28 NZ NZ742210A patent/NZ742210A/en unknown
- 2016-10-28 US US15/771,832 patent/US10864260B2/en active Active
- 2016-10-28 EP EP16795246.4A patent/EP3368070B9/en active Active
-
2018
- 2018-04-27 CL CL2018001130A patent/CL2018001130A1/es unknown
- 2018-04-30 CO CONC2018/0004630A patent/CO2018004630A2/es unknown
- 2018-05-09 ZA ZA2018/03039A patent/ZA201803039B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3003343A1 (en) | 2017-05-04 |
| NZ742210A (en) | 2023-06-30 |
| BR112018008527A2 (pt) | 2018-11-06 |
| MX2018005254A (es) | 2019-10-04 |
| EP3368070B9 (en) | 2023-10-18 |
| CL2018001130A1 (es) | 2018-11-23 |
| IL258976B (en) | 2022-08-01 |
| WO2017072325A1 (en) | 2017-05-04 |
| IL258976A (en) | 2018-06-28 |
| EP3368070A1 (en) | 2018-09-05 |
| US20180311332A1 (en) | 2018-11-01 |
| ZA201803039B (en) | 2022-01-26 |
| AU2016347636A1 (en) | 2018-05-24 |
| EP3368070B1 (en) | 2023-08-30 |
| US10864260B2 (en) | 2020-12-15 |
| AU2016347636B2 (en) | 2021-02-18 |
| ES2960032T3 (es) | 2024-02-29 |
| CA3003343C (en) | 2024-05-28 |
| EP3368070C0 (en) | 2023-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112018075284A2 (pt) | derivados de piperidinila substituída por (hetero)arila, processo para sua preparação e composições farmacêuticas contendo-os | |
| CL2020001048A1 (es) | Anticuerpos monoclonales contra bcma. (divisional solicitud 201800281) | |
| BR112017017025A2 (pt) | métodos e composições para analizar componentes celulares | |
| CL2020003409A1 (es) | Moléculas de unión específicas para cd73 y métodos de fabricación de las mismas (divisional de la solicitud no. 201701154) | |
| CL2018000730A1 (es) | Compuestos heterocíclicos y usos de los mismos | |
| NI201800132A (es) | Nuevos derivados piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| BR112019000970A2 (pt) | proteínas de ligação ao antígeno multiespecíficas e métodos de uso das mesmas | |
| UY37463A (es) | Proteínas de unión | |
| BR112018073739A2 (pt) | proteína de ligação de albumina sérica de domínio único | |
| BR102015032361A8 (pt) | Compostos de quinazolina, usos dos mesmos, composição farmacêutica, kit e artigo de manufatura | |
| SV2018005643A (es) | Composiciones de insulina de rapida accion | |
| BR112017002811A2 (pt) | compostos de pirrolopirimidina usados como agonista de tlr7 | |
| CL2021000028A1 (es) | Anticuerpo multiespecifico (divisional de solicitud 937-2020). | |
| CL2018000819A1 (es) | Anticuerpos biespecíficos anti-cd20 humano/receptor de transferrina humano y métodos para su uso | |
| CR20170425A (es) | Nuevas proteínas específicas para pioverdina y pioquelina | |
| BR112016028476A8 (pt) | compostos, composição, uso de um composto e método para o combate dos fungos nocivos | |
| BR112016011170A8 (pt) | derivados de heteroaril ácido butanoico, seus usos, combinação e composição farmacêutica | |
| BR112018015965A2 (pt) | método para determinação de helicobacter pylori | |
| CL2018001210A1 (es) | Compuestos de criptoficina novedosos y productos conjugados, su preparación y su uso terapéutico. | |
| BR112018006730A2 (pt) | método para preparar um composto, substância ou mistura de substância, uso de pelo menos uma substância ou mistura de substância, composição de fragrância, e, agente. | |
| CO2018004630A2 (es) | Composición de una vacuna de neospora | |
| BR112017025427A2 (pt) | composição farmacêutica oral | |
| BR112015011515A2 (pt) | Composições farmacêuticas de inibidores de cetp | |
| GT201700126A (es) | Ácidos piridil-cicloalquil-carboxílicos sustituidos composiciones que los contienen y usos de los mismos | |
| MX2020004675A (es) | Formulaciones de alcohol de seda. |